Table of Contents

December 2011, Volume 18, Number 6

Commentary

    • Deeqa Ahmed,
    • Ragnhild A Lothe,
    • Edgar Rivedal,
    • and Guro E Lind

    Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors

    Endocr Relat Cancer 18 (6) C31-C34, doi:10.1530/ERC-11-0204 first published on 25 August 2011

Review

    • Odelia Cooper,
    • George Vlotides,
    • Hidenori Fukuoka,
    • Mark I Greene,
    • and Shlomo Melmed

    Expression and function of ErbB receptors and ligands in the pituitary

    Endocr Relat Cancer 18 (6) R197-R211, doi:10.1530/ERC-11-0066 first published on 14 September 2011
    • Carla S Verissimo,
    • Jan J Molenaar,
    • Carlos P Fitzsimons,
    • and Erno Vreugdenhil

    Neuroblastoma therapy: what is in the pipeline?

    Endocr Relat Cancer 18 (6) R213-R231, doi:10.1530/ERC-11-0251 first published on 4 October 2011
    • Federico Gatto and
    • Leo J Hofland

    The role of somatostatin and dopamine D2 receptors in endocrine tumors

    Endocr Relat Cancer 18 (6) R233-R251, doi:10.1530/ERC-10-0334
    • Jenny Welander,
    • Peter Söderkvist,
    • and Oliver Gimm

    Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas

    Endocr Relat Cancer 18 (6) R253-R276, doi:10.1530/ERC-11-0170 first published on 31 October 2011

Article

    • Deniz M Özata,
    • Stefano Caramuta,
    • David Velázquez-Fernández,
    • Pinar Akçakaya,
    • Hong Xie,
    • Anders Höög,
    • Jan Zedenius,
    • Martin Bäckdahl,
    • Catharina Larsson,
    • and Weng-Onn Lui

    The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma

    Endocr Relat Cancer 18 (6) 643-655, doi:10.1530/ERC-11-0082 first published on 22 August 2011
    OPEN ACCESS ARTICLE
    • Fieke Lamers,
    • Ida van der Ploeg,
    • Linda Schild,
    • Marli E Ebus,
    • Jan Koster,
    • Bo R Hansen,
    • Troels Koch,
    • Rogier Versteeg,
    • Huib N Caron,
    • and Jan J Molenaar

    Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe

    Endocr Relat Cancer 18 (6) 657-668, doi:10.1530/ERC-11-0207 first published on 22 August 2011
    • Alessandra Bommarito,
    • Pierina Richiusa,
    • Elvira Carissimi,
    • Giuseppe Pizzolanti,
    • Vito Rodolico,
    • Giovanni Zito,
    • Angela Criscimanna,
    • Francesco Di Blasi,
    • Maria Pitrone,
    • Monica Zerilli,
    • Marco C Amato,
    • Gaetano Spinelli,
    • Valeria Carina,
    • Giuseppe Modica,
    • M Adelfio Latteri,
    • Aldo Galluzzo,
    • and Carla Giordano

    BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy

    Endocr Relat Cancer 18 (6) 669-685, doi:10.1530/ERC-11-0076 first published on 8 September 2011
    • Peng Hou,
    • Dingxie Liu,
    • and Mingzhao Xing

    Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells

    Endocr Relat Cancer 18 (6) 687-697, doi:10.1530/ERC-11-0212 first published on 21 September 2011
    • Carly Jade Dool,
    • Haider Mashhedi,
    • Mahvash Zakikhani,
    • Stéphanie David,
    • Yunhua Zhao,
    • Elena Birman,
    • Joan M Carboni,
    • Marco Gottardis,
    • Marie-José Blouin,
    • and Michael Pollak

    IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer

    Endocr Relat Cancer 18 (6) 699-709, doi:10.1530/ERC-11-0136 first published on 26 September 2011
    • Patrick Brest,
    • Sandra Lassalle,
    • Veronique Hofman,
    • Olivier Bordone,
    • Virginie Gavric Tanga,
    • Christelle Bonnetaud,
    • Chimene Moreilhon,
    • Geraldine Rios,
    • José Santini,
    • Pascal Barbry,
    • Catharina Svanborg,
    • Baharia Mograbi,
    • Bernard Mari,
    • and Paul Hofman

    MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells

    Endocr Relat Cancer 18 (6) 711-719, doi:10.1530/ERC-10-0257 first published on 26 September 2011
    • Philippe L Bedard,
    • Sandeep K Singhal,
    • Michail Ignatiadis,
    • Ian Bradbury,
    • Benjamin Haibe-Kains,
    • Christine Desmedt,
    • Sherene Loi,
    • Dean B Evans,
    • Stefan Michiels,
    • J Michael Dixon,
    • William R Miller,
    • Martine J Piccart,
    • and Christos Sotiriou

    Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer

    Endocr Relat Cancer 18 (6) 721-730, doi:10.1530/ERC-11-0180 first published on 7 October 2011
    • Lisa Zhang,
    • Reza Rahbari,
    • Mei He,
    • and Electron Kebebew

    CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer

    Endocr Relat Cancer 18 (6) 731-742, doi:10.1530/ERC-11-0181 first published on 11 October 2011
    • Maria Grazia Vizioli,
    • Patricia A Possik,
    • Eva Tarantino,
    • Katrin Meissl,
    • Maria Grazia Borrello,
    • Claudia Miranda,
    • Maria Chiara Anania,
    • Sonia Pagliardini,
    • Ettore Seregni,
    • Marco A Pierotti,
    • Silvana Pilotti,
    • Daniel S Peeper,
    • and Angela Greco

    Evidence of oncogene-induced senescence in thyroid carcinogenesis

    Endocr Relat Cancer 18 (6) 743-757, doi:10.1530/ERC-11-0240 first published on 21 September 2011
    • Zhihong Chen,
    • Lora W Forman,
    • Kenneth A Miller,
    • Brandon English,
    • Asami Takashima,
    • Regine A Bohacek,
    • Robert M Williams,
    • and Douglas V Faller

    Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors

    Endocr Relat Cancer 18 (6) 759-771, doi:10.1530/ERC-10-0224 first published on 11 October 2011
    • Dong Wang,
    • Jia-Fu Feng,
    • Ping Zeng,
    • Yun-Hong Yang,
    • Jun Luo,
    • and Yu-Wei Yang

    Total oxidant/antioxidant status in sera of patients with thyroid cancers

    Endocr Relat Cancer 18 (6) 773-782, doi:10.1530/ERC-11-0230 first published on 14 October 2011
    OPEN ACCESS ARTICLE
    • Frédérique Végran,
    • Romain Boidot,
    • Franck Bonnetain,
    • Muriel Cadouot,
    • Sandy Chevrier,
    • and Sarab Lizard-Nacol

    Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma

    Endocr Relat Cancer 18 (6) 783-792, doi:10.1530/ERC-11-0105 first published on 30 August 2011

Letter to the editor

    • Michail Kaklamanos,
    • Ioannis Karoumpalis,
    • Charitini Salla,
    • Dimitrios Thomas,
    • George Kanakis,
    • Krystallenia Alexandraki,
    • Stavros Sougioultzis,
    • Evanthia Diakatou,
    • George Kontogeorgos,
    • and Gregory Kaltsas

    Diagnostic accuracy and clinical significance of the fine needle aspiration Ki-67 labelling index in pancreatic endocrine tumours

    Endocr Relat Cancer 18 (6) L1-L3, doi:10.1530/ERC-10-0191

Erratum

|

This Issue

December 2011; 18 (6)
  1. Commentary
  2. Review
  3. Article
  4. Letter to the editor
  5. Erratum

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most